AMENDMENT TO STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Company

Tonix Pharmaceuticals Holding Corp.

Filed

March 6, 2024

Period of Report

February 27, 2024

Accession Number

0001999371-24-003168